| Name | H2B clustered histone 9 |
| Description | Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2B family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6. [provided by RefSeq, Aug 2015] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n H2BC9 is a member of the histone H2B family that plays key roles in nucleosome assembly and chromatin structure, thereby influencing gene expression and cellular responses. Altered regulation of replication‐dependent histone transcripts—including those related to H2BC9—has been linked to changes in the transcriptional programs that govern cell proliferation, differentiation, and DNA damage responses ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]. For example, modulation of H2B levels through mechanisms such as poly(ADP‐ribose) glycohydrolase (PARG) silencing has been shown to downregulate specific H2B subtypes and impact carcinogen‐induced tumorigenesis, suggesting that proper H2B expression is critical for maintaining chromatin homeostasis and may influence oncogenic processes ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "]."}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition, intracellular peptides derived from histone H2B proteins have been demonstrated to exert cytoprotective effects against cellular stress, indicating that proteolytic fragments of H2B (and by extension, proteins such as H2BC9) may contribute to cell survival pathways ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "]. Clinical studies have further implicated H2B isoforms as potential biomarkers; for instance, elevated expression of certain H2B genes, including those closely related to H2BC9, has been associated with poorer overall survival and altered radiotherapy responsiveness in non‐small‐cell lung cancer patients ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, regulated processing—such as the alternative polyadenylation of H2B transcripts during differentiation or cellular stress—underscores the dynamic role of H2B family genes in adapting chromatin to environmental signals ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]. Emerging proteomic analyses also suggest correlations between H2B expression profiles and broader physiological phenotypes, including aspects of neuropsychiatric traits, which highlights the extensive influence of these histones on cellular function and organismal health ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "].\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, H2BC9 contributes to the regulation of chromatin architecture and gene transcription, with its expression and processing being finely tuned in response to developmental cues and stress. Its dysregulation may influence tumorigenesis and treatment responses, while fragments derived from H2B proteins can have protective cellular roles. These multifaceted functions suggest that H2BC9 and related histone H2B family members represent promising biomarkers and therapeutic targets in cancer and other age‐related diseases.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Vijayalakshmi Kari, Oleksandra Karpiuk, Bettina Tieg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A subset of histone H2B genes produces polyadenylated mRNAs under a variety of cellular conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0063745"}], "href": "https://doi.org/10.1371/journal.pone.0063745"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23717473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23717473"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhuoying Zeng, Jingjing Lu, Desheng Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Poly(ADP-ribose) glycohydrolase silencing-mediated H2B expression inhibits benzo(a)pyrene-induced carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Toxicol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/tox.23034"}], "href": "https://doi.org/10.1002/tox.23034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33044785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33044785"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "C C Café-Mendes, E S Ferro, A S Torrão, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteomics (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jprot.2016.05.025"}], "href": "https://doi.org/10.1016/j.jprot.2016.05.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27321914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27321914"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yun-Qiang Zhang, Ye Yuan, Jun Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Transl Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/atm-21-2963"}], "href": "https://doi.org/10.21037/atm-21-2963"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34430609"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34430609"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Qing Ma, Kai Geng, Ping Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Res Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2021/5963868"}], "href": "https://doi.org/10.1155/2021/5963868"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34518802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34518802"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lei Tian, Hong-Zhao You, Hao Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "iTRAQ-based quantitative proteomic analysis provides insight for molecular mechanism of neuroticism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Proteomics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12014-019-9259-8"}], "href": "https://doi.org/10.1186/s12014-019-9259-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31719821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31719821"}]}]}]}
|
| NCBI Gene ID | 8345 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
H2BC9 has 2,533 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 28 datasets.
Click the + buttons to view associations for H2BC9 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of H2BC9 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of H2BC9 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of H2BC9 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing H2BC9 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with H2BC9 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with H2BC9 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with H2BC9 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving H2BC9 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing H2BC9 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by H2BC9 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of H2BC9 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of H2BC9 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with H2BC9 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by H2BC9 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of H2BC9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving H2BC9 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of H2BC9 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving H2BC9 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving H2BC9 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of H2BC9 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of H2BC9 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of H2BC9 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of H2BC9 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of H2BC9 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of H2BC9 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of H2BC9 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with H2BC9 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving H2BC9 protein from the WikiPathways Pathways 2024 dataset. | |